Steven Cohen’s Sarepta Therapeutics SRPT Stock Holding History

Steven Cohen’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-238,900	Closed	-$4.6M	–	4161
2025 Q3	$4.6M	Buy	238,900 +151,400	+173%	+$2.7M	0.01%	1100
2025 Q2	$1.5M	Buy	87,500 +57,500	+192%	+$2.45M	﹤0.01%	1419
2025 Q1	$1.91M	Buy	+30,000	New	+$3.16M	﹤0.01%	1259
2023 Q4	–	Sell	-20,000	Closed	-$2.42M	–	2774
2023 Q3	$2.42M	Sell	20,000 -10,000	-33%	-$1.13M	0.01%	1087
2023 Q2	$3.44M	Buy	+30,000	New	+$3.87M	0.01%	932
2018 Q3	–	Sell	-25,000	Closed	-$3.31M	–	1206
2018 Q2	$3.31M	Sell	25,000 -25,000	-50%	-$2.36M	0.01%	689
2018 Q1	$3.71M	Buy	+50,000	New	+$3.33M	0.02%	633
2016 Q3	–	Sell	-900,000	Closed	-$17.2M	–	846
2016 Q2	$17.2M	Buy	+900,000	New	+$16.7M	0.12%	207

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Steven Cohen's SRPT Position: Q2 2026 in Review

Steven Cohen opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 510,908 shares worth $9.18M. The stake represents 0.01% of the portfolio and ranks #1340 among its holdings. This is a return to the name: Steven Cohen previously reported a position in SRPT as recently as Q4 2025.

Steven Cohen first reported a position in SRPT in Q2 2014 and has held it in 36 quarters since. The position peaked at $202M in Q3 2016. 320 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Steven Cohen held 510,908 shares of Sarepta Therapeutics worth $9.18M as of Q2 2026.
Sarepta Therapeutics was a new Steven Cohen position in Q2 2026.
Sarepta Therapeutics made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1340 holding.
Steven Cohen first reported a position in Sarepta Therapeutics in Q2 2014 and has held it in 36 quarters since.
Steven Cohen's Sarepta Therapeutics position peaked at $202M in Q3 2016.
320 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.